Jarrow Fem-Dophilus shlf stable 1B VHSC

$27.49 USD

Sale Sold out

Quantity

Probiotic for Women with 30+ Years of Clinical Research
Supports Vaginal and Urinary Tract Health
Shelf-Stable Version of Fem-Dophilus: No Refrigeration Necessary
Clinically-Documented Benefits
More Than 20 Studies Demonstrating Safety and Efficacy
With 2 patented strains: Lacticaseibacillus rhamnosus GR-1® and Limosilactobacillus reuteri RC-14®. These beneficial strains populate the vaginal tract with healthy bacteria to balance the vaginal microbiome and help maintain a healthy vaginal and urinary tract. These two strains are the most clinically published strains for vaginal health worldwide, and were carefully selected due to their effectiveness in these studies. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid, enhances probiotic bacterial survival to the lower intestine, and into the vaginal tract.
Package contains a smaller, Activ-Vial™ moisture-controlled desiccant bottle for better stability of probiotic bacteria
In one randomized clinical trial, 60% of women studied had healthy vaginal flora after 28 days of use at 0.8 billion CFU per day of a probiotic (formulated with L. rhamnosus, GR-1® and L. reuteri, RC-14®) compared to 40% before supplementation. Whereas in the control group (taking 10 billion CFU of common strain, L. rhamnosus GG) there was no improvement in the percentage of women with healthy vaginal flora.